Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response

Korneliusz Golebski(Amsterdam Neuroscience), Janice A. Layhadi(NIHR Imperial Biomedical Research Centre), Ümit Murat Şahiner(Imperial College London), Esther Helen Steveling(University Hospital of Basel), Madison M. Lenormand(NIHR Imperial Biomedical Research Centre), Rachael C. Y. Li(NIHR Imperial Biomedical Research Centre), Suzanne M. Bal(Amsterdam University Medical Centers), Balthasar A. Heesters(Amsterdam University Medical Centers), Gemma Vilà-Nadal(Imperial College London), Oliver Hunewald(Luxembourg Institute of Health), Guillem Montamat(University of Southern Denmark), Feng He(Luxembourg Institute of Health), Markus Ollert(University of Southern Denmark), Oleksandra Fedina(Imperial College London), Mongkol Lao‐Araya(Imperial College London), Susanne J. H. Vijverberg(Amsterdam University Medical Centers), Anke H. Maitland‐van der Zee(Amsterdam University Medical Centers), Cornelis M. van Drunen(Amsterdam University Medical Centers), Wytske J. Fokkens(Amsterdam University Medical Centers), Stephen R. Durham(NIHR Imperial Biomedical Research Centre), Hergen Spits(Amsterdam Neuroscience), Mohamed H. Shamji(NIHR Imperial Biomedical Research Centre)
Immunity
January 14, 2021
Cited by 240Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis